Answers are grounded in this paper and cite their sources.
The English Longitudinal Study of Ageing (ELSA) is an ongoing nationally representative sample of individuals aged 50 and older living in England.1 The study started in 2002, and participants are reassessed every 2 years with face-to-face interviews and self-completion questionnaires. Biomedical assessments take place every 4 years with a home visit from a study nurse who assesses functional capacity and anthropometry and takes blood samples for the extraction of biomarkers and DNA. More than 18 000 people have taken part in the study since its inception, and the data currently available span over 16 years (wave 9 took place in 2018/19). Refreshment samples of new participants have been recruited at waves 3, 4, 6, 7 and 9 to maintain the age profile and ensure that the study remains representative of the English population aged 50 and over. ELSA tracks multiple and complex characteristics of the same individuals as they move through middle age to older age and has collected a wide range of clinical, biological, psychological, economic and social measures, including biomarker and genetic data across the main waves. The study is a collaboration between epidemiology and behavioural science (University College London), economics (Institute for Fiscal Studies), social science (University of Manchester), clinical medicine (Norwich Medical School) and survey specialists (NatCen Social Research). For up-to-date information, see the study website [https://www.elsa-project.ac.uk/]. ELSA data are archived with the UK Data Service [https://ukdataservice.ac.uk] within a few months of completion of each wave, and are accessed by researchers and policy analysts around the world. The study informs policy across many aspects of ageing, including health and social care, retirement and pensions policy and social and civic participation. Internationally, ELSA is one of the sister studies of the Health and Retirement Study (HRS) in the USA, and part of a growing network of longitudinal population studies of ageing around the world. These surveys not only provide data for individual countries but also offer the opportunity for cross-national comparisons of harmonized datasets. For more information, see the Gateway to Global Ageing Data website [https://g2aging.org/]. The ELSA-HCAP Sub-study received ethical approval from the South Central-Berkshire National Health Services (NHS) Research Ethics Committee and was conducted in accordance with the ethical standards of the Declaration of Helsinki. Informed verbal consent was obtained from all participants or their guardians. For more information see Supplementary material available as Supplementary data at IJE online. One of the key epidemiological challenges in the 21st century is that non-communicable diseases, such as cardiovascular disease, stroke and dementia, have become the leading causes of mortality and morbidity.2 Among these, dementia represents one of the most debilitating conditions, with an increased prevalence in individuals aged 65 years and older and double risk with every 5 years’ increase in age after that. Attributable pathologies accounting for dementia at death suggest that age, brain atrophy, total volume loss, vascular changes and disease-related proteins such as TDP-43 and alpha-synuclein all contribute, with Alzheimer’s type pathology alone accounting for only around 20% of cases.3 Early detection and prevention are crucial but challenging, considering the interplay of the established risk factors operating at various points across the life course.4 The operationalization of diagnostic criteria for the ever-changing concepts of mild cognitive impairment and dementia, as well as their diagnostic boundaries, are complex. Yet in most cases, diagnosis involves a medical history and reported or measured changes in cognitive function, as well as behavioural and functional impairments that allow clinicians to gauge the severity of the symptoms presented. A significant challenge is to define what constitutes the normal spectrum of cognitive ageing in contrast to cognitive impairment while taking into consideration specific population norms.5 Despite our ability to identify certain brain pathologies in vivo using neuroimaging and biomarkers,6 a precise diagnostic algorithm remains problematic. The most significant difficulties encountered in diagnosing dementias stem principally from their shared heterogeneous classifications, influenced by multiple and mixed pathologies. Modern conceptualizations highlight preclinical stages reflecting changes that have already taken place in the brain before marked symptoms emerge.7 Crucially, individuals who are clinically diagnosed are only a subset of those with cognitive impairment and dementia, and it is estimated that dementia remains undetected in almost 50% of primary care patients in the UK,8 with even higher rates in other countries. In the absence of a single measurement instrument for dementia identification and classification, international efforts are being made to implement standardized neurocognitive assessments in various population studies. The implementation of the international Harmonised Cognitive Assessment Protocol (HCAP) in the family of studies associated with the Health and Retirement Study offers an opportunity for investigating, in a comparable manner, measures relevant to dementia diagnosis including cognitive, sensory and psychological performance as well as functional abilities in large representative population samples of older adults in both high- and middle-income countries. The overall aim of HCAP is to ascertain and investigate mild cognitive impairment and dementia across the general population worldwide. HCAP involved much more detailed assessments of cognitive impairment and its correlates than was possible in the main waves of ELSA and so was carried out as a sub-study. ELSA-HCAP provides opportunities for identifying potential predictors of cognitive impairment and dementia, as well as the consequences of dementia, in the context of the longitudinal framework of ELSA main waves. The ELSA-HCAP protocol involves an extensive range of cognitive measures coupled with informant interviews on a stratified sub-sample of ELSA participants aged 65 and older. These cognitive measures will be included in an international algorithm aimed to classify dementia, mild cognitive impairment and healthy cognitive function in population studies, with benchmarking against the Cognitive Function and Ageing Study (CFAS), the Aging Demographics and Memory Study (ADAMS) and other studies of cognitive ageing and dementia around the world. The HCAP instrument aims to use international algorithmic approaches to evaluate the prevalence of neurocognitive disorders in people aged over 65 years within each participating country including England, USA, Mexico, South Africa, China and India. Currently, the HCAP Network research group is developing a diagnostic algorithm that will make use of HCAP respondent and informant data to assign a research diagnosis of normal, mild cognitive impairment or dementia. The HCAP project is being carried out in several countries around the world, and as a result, the international implementation of these assessments offers the opportunity for cross-national investigations and comparisons of the biological, medical, social and environmental factors that affect the risk of neurocognitive impairments. Therefore, HCAP represents a promising international platform for investigating and tracking changes in the prevalence of mild cognitive impairment and dementia over time, facilitating country-specific investigations of medical care systems and social policy interventions. Participants were selected for the ELSA-HCAP Sub-study if they were an ELSA core member aged 65 and over at the start of fieldwork in January 2018 (born before 1 January 1953) and had completed an ELSA interview in person at either wave 8 (2016–17) or wave 7 (2014–15). Core members living in care or nursing homes were also eligible, if they had the capacity to consent, or if a consultee/family member agreed to participate on their behalf. Further selections were made based on a sample procedure related to their previous cognitive performance using the modified Telephone Interview Cognitive Screening (mTICS)9 and a diagnosis of Alzheimer’s disease or dementia previously reported (waves 1–8). Three groups were defined using the thresholds on the mTICS 27 items scale: group 1—low cognition (≤6 mTICS27 score) and/or a diagnosis of Alzheimer’s disease or dementia; group 2—moderate cognition (7–11 mTICS27 score) and had never reported a diagnosis of Alzheimer’s disease or dementia; group 3—normal cognition (≥12 mTICS27 score) or unknown for those with missing data on mTICS scores at most recent ELSA waves. ELSA-HCAP was administered to participants across all the range of cognitive abilities, but we oversampled those identified as having low cognitive scores in the most recent ELSA waves. Core members who had proxy interviews (indicating an inability to participate themselves) at both wave 7 and wave 8 were not eligible for ELSA-HCAP. The fieldwork for ELSA-HCAP took place between January 2018 and April 2018, between the ELSA main waves 8 and 9 (Supplementary Figure S1, available as Supplementary data at IJE online). To test the design, materials and procedure for the ELSA-HCAP Sub-study, a dress rehearsal was conducted between August and September 2017. For more information, see Supplementary material, available as Supplementary data at IJE online. Based on the eligibility criteria, around 1800 individuals were sampled for ELSA-HCAP, with the expectation of a 60% response rate. Around half (n = 900) were sampled from cognitive groups 1 (low) and 2 (moderate). Since the number of people eligible for group 1 (n = 334) was small, all eligible members were invited, whereas for those eligible in group 3 (n = 4 610) only 1 in 5 people were invited. The response rate for the ELSA-HCAP study was higher than anticipated. From the 1684 eligible cases, 1273 completed the face-to-face interview, representing a final response rate of 75.6% (Figure 1). Table 1 shows that response rates were generally similar across age and sex, but with a slightly higher response within the 65–69 age group and lower in the 85+ age group. The flow of respondents and informant selection through the study in the English Longitudinal Study of Ageing Harmonised Cognitive Assessment Protocol (ELSA-HCAP) The response among ELSA-HCAP respondents and informants (eligible and completed interviews) ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. Percentage response rates from the completed number of respondents. 1273 represents the total sample of ELSA-HCAP respondents and 1050 represents the total sample of ELSA-HCAP informants. The response among ELSA-HCAP respondents and informants (eligible and completed interviews) ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. Percentage response rates from the completed number of respondents. 1273 represents the total sample of ELSA-HCAP respondents and 1050 represents the total sample of ELSA-HCAP informants. A total of 1050 informant interviews were conducted, representing a response rate of 82.5% of all the eligible sample (n = 1273) contacted. Of these, 194 (18.5%) informant interviews were completed by telephone, and 856 (81.5%) by self-completion questionnaire. The informant relationships with the respondent included spouse/partner (56%), child (22%), grandchild (1%), sibling (3%), parent (3%), friend (10%), carer (0.3%), neighbour (1%) or other (3%). A small number refused to answer (0.4%). The average period an informant reported knowing the respondent was 43 years [standard deviation (SD) = 18; range = 1–82]. Table 2 also shows the response rates among the informant sampling groups (eligible and completed interviews), which were similar across age and sex, with slightly lower rates for informants aged 80 and over. The battery of tests included in the ELSA-HCAP respondent and informant interviews with the correspondence between ELSA main waves ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol; HRS, Health Retirement Study; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease. Wechsler memory scale-IV story administered in this study was ‘Anna Thompson’. The battery of tests included in the ELSA-HCAP respondent and informant interviews with the correspondence between ELSA main waves ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol; HRS, Health Retirement Study; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease. Wechsler memory scale-IV story administered in this study was ‘Anna Thompson’. A weighting procedure was derived for the ELSA-HCAP Sub-study in order to adjust for non-response bias within each of the three cognition groups, especially for the low cognition group, which had the lowest response rate. It involved three components: design weights, non-response weights and a calibration procedure accounting for differential selection probabilities and adjusting for non-response. The final weight for this sub-study represents a combination of the design and non-response weights, which is made available to the users with the ELSA-HCAP data (Supplementary data and Supplementary Table S1, available at IJE online). At the time of this report, only wave 1 of the ELSA-HCAP Sub-study has been completed. However, participants will continue to be included in the ELSA main waves, so it is expected that they will be followed up as part of the study. It is planned that ELSA will continue with assessments every 2 years, nurse visits for biomarkers measurements every 4 years and linkage with registry data, including mortality statistics. To ensure data quality, two researchers scrutinized the data collected, by comparing the results between various tests and the overall performance on the Mini-Mental State Examination (MMSE). The concordance between the distributions of ELSA-HCAP cognitive scores with those published in similar age-matched population studies was also examined. When outliers were identified (±3 standard deviations from the mean), further checks of the paper tests and interview records were made, correcting any errors in data entry (n = 48). The HCAP comprises two interviews, one with the respondent and one with an informant nominated by the respondent. The HCAP respondent interview covers a broad range of cognitive domains (memory, language, executive function, psychomotor speed, problem solving and numeracy) known to be affected by the ageing process. Table 2 summarizes these tests, the majority of which are new to ELSA, although they all are well-established neurocognitive assessments such as Mini-Mental State Examination (MMSE), CERAD (Consortium to Establish a Registry for Alzheimer’s Disease), Word List Memory, Backward Counting Task, Community Screening Interview for Dementia, Logical memory (East Boston Memory Test and ‘Anna Thompson’ story of the Wechsler Memory Scale), CERAD Constructional Praxis (shape drawing), Symbol Digit Modalities Test, HRS Number Series, Raven’s Standard Progressive Matrices Test, and Trail Making. For more detail and see Supplementary Table available as Supplementary data at IJE online. The of the for was also with an test of identification and The of the ELSA-HCAP respondent interview was 1 The ELSA-HCAP informant interview was conducted with a nominated family member or friend who was to the general health of the respondent and evaluate any changes in their cognitive The interview measured the functional of the such as their ability to in of living and and It also the respondent had been previously diagnosed with a disease, other of dementia or Further measures included were the on Cognitive in the Community Screening for Cognitive Research and HRS related to the of time or other Table 2 and Table The of time for which the informant had known the respondent was also The informant interview was completed either a paper self-completion or by a interview using The ELSA-HCAP informant interview took to The ELSA-HCAP Sub-study provides a detailed and clinical of a selected sample of individuals aged 65 and over which be to the of the ELSA population by to those living in the in Table 3 shows the characteristics of the ELSA-HCAP respondent were in and with more a higher of and higher than were more than to be or living with a and to or In were more to and difficulties in the of using a or around the Table 4 the and standard deviation for each cognitive test included in the ELSA-HCAP respondent The performance of was on average than on the verbal and solving tests in memory and abilities and health characteristics of the ELSA-HCAP sample ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. symptoms were using the of 9 on the of the for and health characteristics of the ELSA-HCAP sample ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. symptoms were using the of 9 on the of the for and standard deviation of the cognitive tests included in the ELSA-HCAP respondent interview ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. Mini-Mental Health Retirement Interview for Cognitive CERAD, Consortium to Establish a Registry for Alzheimer’s Community Screening for Boston Memory and standard deviation of the cognitive tests included in the ELSA-HCAP respondent interview ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. Mini-Mental Health Retirement Interview for Cognitive CERAD, Consortium to Establish a Registry for Alzheimer’s Community Screening for Boston Memory The longitudinal of ELSA provides opportunities for the of of cognitive impairment and dementia over the 16 years of data, including the of cognitive, and health These data provide to the and of the many biological, medical and social factors that the of clinical symptoms of dementia. have been published using ELSA data on cognitive and dementia a wide range of see However, these the implementation of HCAP Sub-study and we a selection of to the broad spectrum of factors that be related to cognitive and dementia. In ELSA, information dementia has to been through a diagnosis of dementia or Alzheimer’s disease and informant interviews) the on Cognitive in the A proxy interview is carried out with a nominated person a family the core member is not or to take part but that a interview on their behalf. These measures have been in a number of studies to of dementia and to investigate and other risk factors associated with such as social and social and as well as a range of risk factors such as sensory and the waves of data an of cognitive tests has been administered including measures of verbal verbal and in to the of cognitive abilities such as ability and These have been to investigate the between cognitive performance and of sensory and international comparisons of cognitive performance have been conducted across and older adults in and the The ELSA-HCAP measures to the opportunities for international comparisons of the context of cognitive impairment and algorithmic approaches to dementia the ELSA-HCAP battery of tests has with other relevant studies such as the Cognitive Function and Ageing and Memory Study Memory and Aging and dementia be The ELSA-HCAP Sub-study is currently and a be to of in this detailed neuroimaging to the study also the research of brain changes related to healthy ageing from the of and associated with various neurocognitive with detailed functional specific and and diagnostic is that the study sample is of ELSA was to be representative of the population of older people in in only of the older population in were from to the the number of ELSA-HCAP participants who were at the time of the interview was low (n = to more of the that make the HCAP Sub-study from it being in biomarkers have been in the study sample every 4 years since Study have collected blood for the of and including and blood and 1 and other biomarkers that be in to many ageing In to and health measures, was carried out on ELSA participants of using the same as in the risk scores for Alzheimer’s disease and dementia have been using results from the study conducted by the of Alzheimer’s and have been made available through the UK Data offers a of data for various or as well as the potential for and participants in ELSA-HCAP will be followed up in waves of data it will be possible to the consequences of cognitive impairment for family and social and information has the potential to the for health and social care to this of the and other policy related to older and The ELSA-HCAP data, including the individual items and the derived scores for each of the respondent and informant interviews, have been made available UK Data Service The ELSA-HCAP study number is The main ELSA study is and is The person to for the ELSA-HCAP study is The Harmonised Cognitive Assessment Protocol Sub-study of the English Longitudinal Study of Ageing 1273 and aged 65 and was up in 2018 to ascertain the prevalence of neurocognitive disorders such as cognitive impairment and dementia and to investigate the risk factors and in these across The ELSA-HCAP protocol represents a more extensive range of cognitive measures than those collected in waves of the English Longitudinal Study of Ageing a broad range of cognitive domains such as language, executive function, psychomotor speed, problem solving and which are known to be affected by the ageing process. The performance of was on average than on the Mini-Mental State verbal and solving tests in memory and abilities However, it be that of were higher among than The harmonized cognitive measures will to an international algorithm aimed at mild cognitive impairment and dementia, benchmarking against the Cognitive Function and Ageing Study (CFAS), Aging Demographics and Memory Study (ADAMS) and other cognitive ageing studies around the world. For new and data at Supplementary data are available at IJE online. The English Longitudinal Study of Ageing Harmonised Cognitive Assessment Protocol (ELSA-HCAP) is by the National on Aging and at the of and Health College The English Longitudinal Study of Ageing is by the National on Aging and by a of UK by the and Social Research since 2018, by the National for Health The English Longitudinal Study of Ageing (ELSA) was by a of researchers based at College the for Fiscal of and Social The ELSA-HCAP Sub-study has been being carried out by and the of and Health at College with from of of and The National on Aging had in this to ELSA-HCAP participants for their to the study and the for the also to all our in and from the HRS of USA, for their in a similar protocol across of and for their to use the and for their on interview of of and College for their this and College for the and and the and at stages of the project the implementation of the harmonized cognitive protocol in ELSA-HCAP, a similar as in the and all the material and the and to the fieldwork implementation and were in of data and checks of the data and its and were for the of this project and its the of the and all and the of the any of the data and materials in this
No takes yet. Share an insight, caveat, or question.
Cadar et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: